{"id":"https://openalex.org/W2016442644","doi":"https://doi.org/10.1111/j.1749-6632.2000.tb05369.x","title":"Bidirectional Heterologous Desensitization of Opioid and Chemokine Receptors","display_name":"Bidirectional Heterologous Desensitization of Opioid and Chemokine Receptors","publication_year":2000,"publication_date":"2000-01-01","ids":{"openalex":"https://openalex.org/W2016442644","doi":"https://doi.org/10.1111/j.1749-6632.2000.tb05369.x","mag":"2016442644","pmid":"https://pubmed.ncbi.nlm.nih.gov/11268344"},"language":"en","primary_location":{"id":"doi:10.1111/j.1749-6632.2000.tb05369.x","doi":"https://doi.org/10.1111/j.1749-6632.2000.tb05369.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1749-6632.2000.tb05369.x","pdf_url":null,"source":{"id":"https://openalex.org/S8802318","display_name":"Annals of the New York Academy of Sciences","issn_l":"0077-8923","issn":["0077-8923","1749-6632"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074854724","display_name":"Thomas J. Rogers","orcid":"https://orcid.org/0000-0002-9189-8105","observed_orcids":["https://orcid.org/0000-0002-9189-8105"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I84392919","display_name":"Temple University","ror":"https://ror.org/00kx1jb78","country_code":"US","type":"education","lineage":["https://openalex.org/I84392919"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"T. J. ROGERS","raw_affiliation_strings":["Department of Microbiology and Immunology, Center for Substance Abuse Research, Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA. rogerst@astro.ocis.temple.edu","Laboratory of Molecular Immunoregulation, Division of Basic Sciences, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702\u20101201, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology and Immunology, Center for Substance Abuse Research, Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA. rogerst@astro.ocis.temple.edu","institution_ids":["https://openalex.org/I84392919"]},{"raw_affiliation_string":"Laboratory of Molecular Immunoregulation, Division of Basic Sciences, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702\u20101201, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075985191","display_name":"Amber D. Steele","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I84392919","display_name":"Temple University","ror":"https://ror.org/00kx1jb78","country_code":"US","type":"education","lineage":["https://openalex.org/I84392919"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. D. STEELE","raw_affiliation_strings":["Department of Microbiology and Immunology, Center for Substance Abuse Research, and the Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology and Immunology, Center for Substance Abuse Research, and the Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA","institution_ids":["https://openalex.org/I84392919"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067466991","display_name":"O. M. Zack Howard","orcid":"https://orcid.org/0000-0002-0505-7052","observed_orcids":["https://orcid.org/0000-0002-0505-7052"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"O. M.Z. HOWARD","raw_affiliation_strings":["Laboratory of Molecular Immunoregulation, Division of Basic Sciences, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Immunoregulation, Division of Basic Sciences, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042240287","display_name":"Joost J. Oppenheim","orcid":"https://orcid.org/0000-0003-0271-7921","observed_orcids":["https://orcid.org/0000-0003-0271-7921"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. J. OPPENHEIM","raw_affiliation_strings":["Laboratory of Molecular Immunoregulation, Division of Basic Sciences, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Immunoregulation, Division of Basic Sciences, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5074854724"],"corresponding_institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I84392919"],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.2941,"has_fulltext":false,"cited_by_count":95,"citation_normalized_percentile":{"value":0.25393701,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"917","issue":"1","first_page":"19","last_page":"28"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.8637999892234802,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.8637999892234802,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.1265999972820282,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/opioid-receptors","display_name":"opioid receptors","score":0.8450000286102295},{"id":"https://openalex.org/keywords/chemokine-receptors","display_name":"chemokine receptors","score":0.9919999837875366},{"id":"https://openalex.org/keywords/heterologous-desensitization","display_name":"heterologous desensitization","score":0.9769999980926514},{"id":"https://openalex.org/keywords/mu-opioid-receptor","display_name":"mu-opioid receptor","score":0.7979999780654907},{"id":"https://openalex.org/keywords/delta-opioid-receptor","display_name":"delta opioid receptor","score":0.9729999899864197},{"id":"https://openalex.org/keywords/kappa-opioid-receptor","display_name":"kappa opioid receptor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ccl5","display_name":"RANTES","score":0.8180000185966492},{"id":"https://openalex.org/keywords/sdf-1alpha","display_name":"SDF-1\u03b1","score":0.9660000205039978},{"id":"https://openalex.org/keywords/met-enkephalin","display_name":"met-enkephalin","score":0.9129999876022339},{"id":"https://openalex.org/keywords/damgo","display_name":"DAMGO","score":0.8650000095367432},{"id":"https://openalex.org/keywords/t-lymphocyte-chemotaxis","display_name":"T lymphocyte chemotaxis","score":0.8130000233650208},{"id":"https://openalex.org/keywords/monocyte-chemotaxis","display_name":"monocyte chemotaxis","score":0.9929999709129333},{"id":"https://openalex.org/keywords/leukocyte-migration","display_name":"leukocyte migration","score":0.9210000038146973},{"id":"https://openalex.org/keywords/jurkat-cells","display_name":"Jurkat cells","score":0.6930000185966492}],"concepts":[{"id":"https://openalex.org/C2776401185","wikidata":"https://www.wikidata.org/wiki/Q5204254","display_name":"DAMGO","level":5,"score":0.7313189506530762},{"id":"https://openalex.org/C54166955","wikidata":"https://www.wikidata.org/wiki/Q658145","display_name":"Chemotaxis","level":3,"score":0.5550277829170227},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.547239363193512},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.48687830567359924},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4718097448348999},{"id":"https://openalex.org/C2781184567","wikidata":"https://www.wikidata.org/wiki/Q107244","display_name":"Monocyte","level":2,"score":0.4546116590499878},{"id":"https://openalex.org/C2779779143","wikidata":"https://www.wikidata.org/wiki/Q3493547","display_name":"Desensitization (medicine)","level":3,"score":0.41781026124954224},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4100058674812317},{"id":"https://openalex.org/C2777803847","wikidata":"https://www.wikidata.org/wiki/Q325101","display_name":"Enkephalin","level":4,"score":0.4072816073894501},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.37111103534698486},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36808377504348755},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35778969526290894},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26776349544525146},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0488189160823822}],"mesh":[{"descriptor_ui":"D002634","descriptor_name":"Chemotaxis, Leukocyte","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009000","descriptor_name":"Monocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009000","descriptor_name":"Monocytes","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011957","descriptor_name":"Receptors, Opioid","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018925","descriptor_name":"Chemokines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D019707","descriptor_name":"Receptors, Chemokine","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1749-6632.2000.tb05369.x","doi":"https://doi.org/10.1111/j.1749-6632.2000.tb05369.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1749-6632.2000.tb05369.x","pdf_url":null,"source":{"id":"https://openalex.org/S8802318","display_name":"Annals of the New York Academy of Sciences","issn_l":"0077-8923","issn":["0077-8923","1749-6632"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"journal-article"},{"id":"pmid:11268344","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11268344","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1010641969","display_name":null,"funder_award_id":"DA 06650","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G201478877","display_name":null,"funder_award_id":"DA-11130","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G2152099631","display_name":"Opioids, Cannabinoids, Chemokines: Functional Implications of Cross-Talk","funder_award_id":"R01DA006650","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G8725314152","display_name":"OPIOIDS AND T CELL DIFFERENTIATION","funder_award_id":"R01DA011130","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W1600804236","https://openalex.org/W1617037549","https://openalex.org/W1834168775","https://openalex.org/W1870043436","https://openalex.org/W1971491668","https://openalex.org/W1978006527","https://openalex.org/W1981334669","https://openalex.org/W1981876334","https://openalex.org/W1982092413","https://openalex.org/W1982515439","https://openalex.org/W1984511769","https://openalex.org/W1985963157","https://openalex.org/W1991459803","https://openalex.org/W1993308000","https://openalex.org/W1994157194","https://openalex.org/W2009182086","https://openalex.org/W2009742151","https://openalex.org/W2010807957","https://openalex.org/W2011242484","https://openalex.org/W2011837650","https://openalex.org/W2020309038","https://openalex.org/W2023645046","https://openalex.org/W2031074677","https://openalex.org/W2033852796","https://openalex.org/W2035646853","https://openalex.org/W2042837551","https://openalex.org/W2045106976","https://openalex.org/W2047564894","https://openalex.org/W2055299062","https://openalex.org/W2057648252","https://openalex.org/W2060221505","https://openalex.org/W2062945620","https://openalex.org/W2068405379","https://openalex.org/W2068711964","https://openalex.org/W2069717662","https://openalex.org/W2074757377","https://openalex.org/W2079520721","https://openalex.org/W2080191413","https://openalex.org/W2084183229","https://openalex.org/W2085497505","https://openalex.org/W2086805594","https://openalex.org/W2094999165","https://openalex.org/W2095736624","https://openalex.org/W2152885406","https://openalex.org/W2167609321","https://openalex.org/W2171944465","https://openalex.org/W2252306055","https://openalex.org/W2273246438","https://openalex.org/W2408935825","https://openalex.org/W2468579349"],"related_works":["https://openalex.org/W2035646853","https://openalex.org/W7097788964","https://openalex.org/W1971491668","https://openalex.org/W2086990722","https://openalex.org/W1996183419","https://openalex.org/W2020309038","https://openalex.org/W2038958959","https://openalex.org/W2020620814","https://openalex.org/W2028182724","https://openalex.org/W2417847656"],"abstract_inverted_index":{"Opioids":[0],"are":[1],"known":[2],"to":[3,27,85,138,154,172,192],"suppress":[4],"a":[5,64,86,91,107,167],"number":[6,87],"of":[7,9,33,81,88,93,170,182,184,194],"elements":[8],"the":[10,34,78,114,134,139,143,152,155,173,185],"immune":[11],"response,":[12],"including":[13],"antimicrobial":[14],"resistance,":[15],"antibody":[16],"production,":[17],"and":[18,38,42,45,60,69,74,102,187],"delayed-type":[19],"hypersensitivity.":[20],"Phagocytic":[21],"cells":[22],"may":[23],"be":[24],"particularly":[25],"susceptible":[26],"opioid":[28,131,186],"administration,":[29],"since":[30],"reduced":[31],"production":[32],"cytokines":[35],"IL-1,":[36],"IL-6":[37],"TNF-alpha,":[39],"monocyte-mediated":[40],"phagocytosis,":[41],"both":[43,58],"neutrophil":[44],"monocyte":[46],"chemotaxis":[47],"have":[48,55,120],"all":[49],"been":[50],"well":[51],"established.":[52],"Earlier":[53],"studies":[54],"shown":[56],"that":[57,99,124,162,180],"mu-":[59,73],"delta-opioid":[61,75],"agonists":[62,104],"induce":[63,106],"chemotactic":[65,79,108,136],"response":[66,80,109,137,153,169],"in":[67,110],"monocytes":[68,171],"neutrophils.":[70],"In":[71],"addition,":[72],"administration":[76],"inhibited":[77],"these":[82],"cell":[83],"populations":[84],"chemokines":[89],"through":[90],"process":[92],"heterologous":[94],"desensitization.":[95],"We":[96],"report":[97],"here":[98],"mu-,":[100],"delta-,":[101],"kappa-opioid":[103],"also":[105],"T":[111],"lymphocytes.":[112],"Using":[113],"human":[115],"T-cell":[116],"line":[117],"Jurkat,":[118],"we":[119,160],"confirmed":[121],"previous":[122],"observations":[123],"pre-incubation":[125],"with":[126,147,164],"met-enkephalin":[127],"(MetEnk),":[128],"an":[129],"endogenous":[130],"agonist,":[132],"prevents":[133],"subsequent":[135,168],"chemokine":[140,156,188],"RANTES.":[141],"On":[142],"other":[144],"hand,":[145],"treatment":[146],"MetEnk":[148],"does":[149],"not":[150],"alter":[151],"SDF-1":[157],"alpha.":[158],"Moreover,":[159],"found":[161],"pre-treatment":[163],"RANTES":[165],"prevented":[166],"mu-opioid":[174],"agonist":[175],"DAMGO.":[176],"These":[177],"results":[178],"suggest":[179],"activation":[181],"members":[183],"receptor":[189],"families":[190],"leads":[191],"downregulation":[193],"each":[195],"other's":[196],"leukocyte":[197],"migratory":[198],"activities.":[199]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}